Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.47 [1.14-1.88],0.0024252414645879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.38 [1.11-1.72],0.00355918340872127,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM2,Paralemmin-2,Inverse variance weighted,8,1.37 [1.1-1.71],0.00499182177020243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.29 [1.08-1.55],0.00515816074441367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.71 [0.56-0.91],0.00558709192688291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,UMOD,Uromodulin,Inverse variance weighted,29,1.12 [1.03-1.21],0.00640040664962556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.21 [1.05-1.39],0.00754874879372456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.1 [1.02-1.18],0.00828088070698405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSC2,Desmocollin-2,Inverse variance weighted,9,0.76 [0.61-0.93],0.00829037395495721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FBLN2,Fibulin-2,Inverse variance weighted,11,0.83 [0.72-0.96],0.0119095035775918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.22 [1.04-1.44],0.0141615491684806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.51 [0.3-0.88],0.0154040116448262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.25 [1.04-1.51],0.0171568595581703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.84 [0.73-0.97],0.0175590942017448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.35 [1.05-1.73],0.0179307587460462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.91 [0.83-0.98],0.0191161620533076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.5 [0.28-0.9],0.0196856411572246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.1 [1.02-1.2],0.0206050513865257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.58 [0.37-0.93],0.0221905558604088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OCLN,Occludin,Inverse variance weighted,2,1.62 [1.07-2.46],0.023706443006715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.13 [1.02-1.25],0.0244669854449533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.22 [0.06-0.84],0.026253728913098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.75 [0.57-0.97],0.0295014895791324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3D,Protein FAM3D,Inverse variance weighted,17,1.29 [1.03-1.62],0.0295102839671261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COLEC12,Collectin-12,Inverse variance weighted,11,1.26 [1.02-1.55],0.0297802008053347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.22 [1.02-1.46],0.0316026274612481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.74 [0.56-0.98],0.0364284028034677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.39 [1.02-1.91],0.0380641069289031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EDN1,Endothelin-1,Inverse variance weighted,3,1.34 [1.02-1.77],0.0386355620213745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.32 [1.01-1.72],0.0399187313502201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.87 [0.76-0.99],0.0401366336100575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.91 [0.83-1],0.0434544551420408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.24 [0.06-0.97],0.0445894630217294,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CFD,Complement factor D,Inverse variance weighted,11,1.2 [1-1.43],0.0446109532043208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.05 [1-1.11],0.0529000910236006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.2 [1-1.44],0.0538249563969084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.53 [0.99-2.37],0.0562039762980792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.87 [0.76-1],0.0563349514609055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.16 [1-1.34],0.0565168499624936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.22 [0.05-1.04],0.0566320134318282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NRP1,Neuropilin-1,Inverse variance weighted,12,0.86 [0.74-1],0.0577799398739901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,7,0.77 [0.59-1.01],0.0631790574511939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.55 [0.97-2.45],0.0643929895570785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.61 [0.96-2.7],0.0706202371104939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.62 [0.37-1.04],0.0711747348159435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,0.92 [0.84-1.01],0.0715635816708561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.12 [0.99-1.27],0.0722183069701554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,0.9 [0.8-1.01],0.0759850817397007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.76 [0.57-1.03],0.07726599910387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.93 [0.86-1.01],0.0794751418338621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.72 [0.5-1.04],0.0803260424299179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.24 [0.97-1.57],0.0805405304268541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.91 [0.81-1.01],0.088012609060862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.49 [0.94-2.36],0.0902309038275753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCG2,Secretogranin-2,Wald ratio,1,0.37 [0.11-1.18],0.091478086353798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,9,1.18 [0.97-1.42],0.0942522152695109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.07 [0.99-1.16],0.0956169302516335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPPC,C-type natriuretic peptide,Wald ratio,1,0.33 [0.09-1.22],0.0967451559679107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.86 [0.71-1.03],0.0975767465256477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.05 [0.99-1.12],0.0978643018532193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.76 [0.54-1.06],0.100678627829591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.93 [0.85-1.02],0.102633093599321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.76 [0.55-1.06],0.10325979248172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.66 [0.4-1.1],0.109825183813023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SDC1,Syndecan-1,Inverse variance weighted,2,1.38 [0.93-2.05],0.111402934822119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,1.34 [0.93-1.91],0.112487211047804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.26 [0.95-1.67],0.112711626547905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,4,0.63 [0.36-1.12],0.113341263410259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.32 [0.93-1.87],0.11952763244588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.94 [0.86-1.02],0.121274550877592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.29 [0.93-1.78],0.121919186046519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.08 [0.98-1.2],0.123359747676164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.11 [0.97-1.26],0.123598314468274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.61 [0.88-2.96],0.124853965304979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.22 [0.95-1.57],0.125325839832193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.64 [0.37-1.13],0.126065794467599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.58 [0.29-1.17],0.127147066702336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP3,Stromelysin-1,Inverse variance weighted,34,0.91 [0.81-1.03],0.128992834784118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.53 [0.87-2.7],0.13894988991855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.85 [0.69-1.05],0.140176073990788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAYN,Layilin,Inverse variance weighted,20,0.89 [0.76-1.04],0.148639406224488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.17 [0.94-1.46],0.149616239907639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.18 [0.94-1.47],0.150320510606636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.27 [0.91-1.77],0.153723491605296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.29 [0.91-1.84],0.155463672857916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.05 [0.98-1.12],0.157044911403585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,23,1.08 [0.97-1.21],0.158070058093157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,14,1.09 [0.97-1.23],0.159487997808279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN4,CCN family member 4,Inverse variance weighted,27,1.07 [0.97-1.18],0.165569976663061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,0.92 [0.82-1.04],0.175661110710169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.75 [0.49-1.14],0.175932787521929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.9 [0.77-1.05],0.176099149422872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.93 [0.83-1.03],0.177151852030775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.91 [0.8-1.04],0.18137760402526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.04 [0.98-1.1],0.181975962778807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.95 [0.88-1.03],0.184801138400882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK4,Kallikrein-4,Inverse variance weighted,17,1.08 [0.96-1.22],0.185172499753823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,22,1.08 [0.96-1.2],0.189986849654118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BOC,Brother of CDO,Inverse variance weighted,6,1.16 [0.93-1.46],0.192186665303691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.16 [0.93-1.45],0.194913192597548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.89 [0.74-1.06],0.194939988730161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.04 [0.98-1.11],0.197607817296274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS27,Serine protease 27,Inverse variance weighted,5,0.88 [0.72-1.07],0.205132404115576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.1 [0.95-1.29],0.206666070029568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,2.8 [0.57-13.87],0.20719163765379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.78 [0.54-1.15],0.210312959138028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.08 [0.96-1.22],0.210828267834888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,1.17 [0.92-1.49],0.211687748164869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.07 [0.96-1.18],0.213578816973089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RETN,Resistin,Inverse variance weighted,9,1.1 [0.95-1.27],0.216070839121629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,1.22 [0.89-1.69],0.216073362932504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPY30,Protein dpy-30 homolog,Wald ratio,1,2.22 [0.63-7.9],0.216327641607933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,1.11 [0.94-1.31],0.219515052214119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MUC13,Mucin-13,Inverse variance weighted,9,0.87 [0.7-1.09],0.221756595899613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BSG,Basigin,Wald ratio,1,1.28 [0.86-1.9],0.224872958707106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGF,Placenta growth factor,Inverse variance weighted,2,0.42 [0.1-1.71],0.227005321297812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.67 [0.72-3.86],0.230484264084229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.95 [0.86-1.04],0.230927075649081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.09 [0.95-1.26],0.2310039909499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.58 [0.23-1.43],0.233243887056834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.04 [0.97-1.11],0.233491942242882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRN,Agrin,Inverse variance weighted,17,1.11 [0.94-1.3],0.234940996515189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.06 [0.96-1.17],0.235233672188246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.16 [0.91-1.47],0.235627706205382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.91 [0.78-1.06],0.236357277568452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.94 [0.84-1.04],0.237462925177864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,0.9 [0.75-1.08],0.239143014975151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.92 [0.79-1.06],0.241422249622392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.82 [0.58-1.15],0.242059232646594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.04 [0.97-1.12],0.245722417657426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.9 [0.74-1.08],0.246710285446179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.32 [0.83-2.09],0.246774983080489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,12,0.88 [0.71-1.09],0.252688923902595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.72 [0.42-1.26],0.252749600177925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.71 [0.39-1.28],0.253429911488334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD83,CD83 antigen,Inverse variance weighted,5,1.17 [0.89-1.55],0.255555783807434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.95 [0.86-1.04],0.256855447013811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.86 [0.67-1.12],0.258081708915334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.1 [0.93-1.29],0.258426299927252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LMNB2,Lamin-B2,Wald ratio,1,2.19 [0.56-8.57],0.259481147925712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,2.08 [0.58-7.46],0.259997863233645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.03 [0.98-1.09],0.260331991689728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLK1,Protein delta homolog 1,Inverse variance weighted,25,1.07 [0.95-1.22],0.261131103473806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.23 [0.86-1.75],0.26464602564778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.11 [0.92-1.33],0.264805260055463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,1.07 [0.95-1.2],0.26854228556037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.66 [0.32-1.38],0.271669184778502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.28 [0.82-1.99],0.272053824530755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.95 [0.87-1.04],0.273540784129946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSTB,Cystatin-B,Inverse variance weighted,28,1.06 [0.95-1.18],0.273829616829745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK11,Kallikrein-11,Inverse variance weighted,6,1.1 [0.92-1.32],0.277505296230563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,0.95 [0.87-1.04],0.278125209080237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.05 [0.96-1.16],0.280104121495704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD48,CD48 antigen,Inverse variance weighted,18,0.95 [0.87-1.04],0.280187320731901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.12 [0.91-1.37],0.28222949446165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,1.09 [0.93-1.26],0.282333640764548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST3,Cystatin-C,Inverse variance weighted,10,0.91 [0.77-1.08],0.283577059360785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.1 [0.93-1.3],0.286189656140818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.91 [0.76-1.09],0.292834562337141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.17 [0.87-1.57],0.294138593243225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,1.17 [0.87-1.57],0.294904246819882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH7,Protocadherin-7,Inverse variance weighted,3,0.79 [0.51-1.23],0.297811522640518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.16 [0.88-1.53],0.303695954296109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.85 [0.62-1.16],0.307278112785597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.82 [0.56-1.2],0.314943134161549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.04 [0.96-1.12],0.315068889894905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,0.93 [0.8-1.07],0.317413276338647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,11,0.89 [0.7-1.12],0.321424514799021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.22 [0.82-1.82],0.322572926748954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,XCL1,Lymphotactin,Inverse variance weighted,31,0.96 [0.88-1.04],0.323723173706657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AMBP,Protein AMBP,Inverse variance weighted,3,0.83 [0.58-1.2],0.326043590521602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.21 [0.83-1.77],0.326525933147204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN15,Lipocalin-15,Inverse variance weighted,20,1.04 [0.96-1.14],0.329296806001423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.44 [0.69-3.02],0.329910971952934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.74 [0.4-1.36],0.332495693993028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.95 [0.87-1.05],0.332759934559805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.86 [0.63-1.17],0.336766407579365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.07 [0.93-1.22],0.338126372808546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.7 [0.34-1.46],0.339056708158224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN5,CCN family member 5,Inverse variance weighted,8,1.27 [0.78-2.06],0.339187510191313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSL,Cathepsin L1,Wald ratio,1,0.56 [0.17-1.84],0.339409538075718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.05 [0.95-1.15],0.344806983933322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL16,Pro-interleukin-16,Inverse variance weighted,16,1.07 [0.93-1.22],0.346704829937103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST6,Cystatin-M,Inverse variance weighted,2,0.8 [0.51-1.27],0.348014375585968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.03 [0.96-1.11],0.348249597690696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.14 [0.87-1.48],0.349470276830283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.77 [0.44-1.34],0.355707146538867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.06 [0.93-1.21],0.357966429592424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.86 [0.62-1.19],0.358609633392461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.13 [0.87-1.48],0.358996457567222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.23 [0.79-1.91],0.359294138621524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.95 [0.84-1.06],0.364744214377497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.08 [0.91-1.27],0.367230586596895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.94 [0.83-1.07],0.37101858183502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.36 [0.69-2.67],0.371222410084691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.96 [0.88-1.05],0.372022011484971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.8 [0.49-1.31],0.374310303396402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,F3,Tissue factor,Inverse variance weighted,11,1.1 [0.89-1.34],0.375871501536151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.95 [0.84-1.07],0.376584379775005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.86 [0.63-1.19],0.377727487079996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.09 [0.9-1.31],0.37814788248452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.67 [0.27-1.64],0.378256499160777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH1,Protocadherin-1,Wald ratio,1,0.74 [0.38-1.45],0.378732417682027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANXA5,Annexin A5,Inverse variance weighted,2,0.79 [0.47-1.33],0.381307189886999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.85 [0.58-1.23],0.381891495448927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD302,CD302 antigen,Inverse variance weighted,9,0.91 [0.75-1.12],0.384332687769666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.8 [0.49-1.32],0.386125392078583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.17 [0.82-1.67],0.39475450816732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,1.06 [0.92-1.23],0.395665558808876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.05 [0.94-1.17],0.396433644862116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.07 [0.92-1.25],0.397809750102065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.33 [0.69-2.57],0.398971911356292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.06 [0.93-1.2],0.4003176814792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.88 [0.64-1.19],0.401089674145113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.96 [0.87-1.06],0.401336665424302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.97 [0.9-1.04],0.405430012410392,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.97 [0.89-1.05],0.408471925742725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MB,Myoglobin,Wald ratio,1,1.85 [0.43-7.96],0.411217539834476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.08 [0.89-1.32],0.415075037428522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.08 [0.9-1.3],0.420541507474526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.04 [0.94-1.16],0.424457438478689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.04 [0.94-1.16],0.425948658144928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALB1,Calbindin,Inverse variance weighted,2,0.78 [0.42-1.45],0.42825463077123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD276,CD276 antigen,Inverse variance weighted,20,1.04 [0.94-1.14],0.43200559002376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.89 [0.66-1.2],0.4337873582416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.11 [0.85-1.46],0.436527141550567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.11 [0.86-1.43],0.436909484681476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.35 [0.63-2.87],0.43815761163946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.41 [0.59-3.39],0.441323413171692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.12 [0.84-1.51],0.441395837478807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NXPH3,Neurexophilin-3,Inverse variance weighted,11,0.94 [0.8-1.1],0.447159476149181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.81-1.63],0.448206046896462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON1,Spondin-1,Inverse variance weighted,21,0.94 [0.8-1.1],0.449273022786675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.22 [0.72-2.05],0.453577288155563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.86 [0.59-1.27],0.458766757689163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS9,Galectin-9,Inverse variance weighted,26,0.96 [0.85-1.07],0.460573135734896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.93 [0.78-1.12],0.464711179982627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,1.05 [0.91-1.22],0.47618836430266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.95 [0.83-1.09],0.477097867459585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.05 [0.92-1.19],0.479315306913587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.79 [0.42-1.51],0.481257340596284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.09 [0.86-1.39],0.485496883121241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.07 [0.89-1.28],0.486760423604293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.06 [0.9-1.25],0.488632899624363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD160,CD160 antigen,Inverse variance weighted,11,0.95 [0.83-1.09],0.493390918553281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.98 [0.91-1.05],0.496519587637513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.9 [0.67-1.21],0.501617904463791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.9-1.24],0.504263188296302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.08 [0.85-1.38],0.505369340461949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VGF,Neurosecretory protein VGF,Wald ratio,1,0.6 [0.13-2.71],0.506979828950318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.94 [0.79-1.12],0.507626853669139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.1 [0.82-1.49],0.509669658743166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH3,Cadherin-3,Inverse variance weighted,2,0.81 [0.43-1.53],0.516559614313889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS4,Galectin-4,Inverse variance weighted,4,1.12 [0.8-1.57],0.517281393919358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.24 [0.64-2.4],0.519382790892114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.1 [0.82-1.49],0.52203353379622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.95 [0.82-1.11],0.523333167274415,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.2 [0.69-2.08],0.523685303173466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PENK,Proenkephalin-A,Inverse variance weighted,19,1.05 [0.91-1.21],0.527135205445546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DRAXIN,Draxin,Inverse variance weighted,13,0.96 [0.86-1.08],0.527224183685125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.92 [0.71-1.19],0.530425087872737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM,Paralemmin-1,Inverse variance weighted,6,0.92 [0.7-1.21],0.533744388888996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MATN2,Matrilin-2,Inverse variance weighted,18,0.95 [0.79-1.13],0.534895979714948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.04 [0.91-1.19],0.536009232189817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.52 [0.4-5.74],0.536799373977606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GUCA2A,Guanylin,Inverse variance weighted,9,0.93 [0.72-1.19],0.545189560217761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.95 [0.81-1.12],0.548059809957319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NFASC,Neurofascin,Inverse variance weighted,15,0.96 [0.83-1.11],0.550610491050159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,22,1.03 [0.93-1.14],0.551010706593544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MDK,Midkine,Inverse variance weighted,4,1.11 [0.78-1.59],0.557648665116542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.06 [0.87-1.29],0.557969543318214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP6,Gastrotropin,Wald ratio,1,0.88 [0.58-1.34],0.561510998699987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.22 [0.62-2.37],0.564530757951484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.06 [0.86-1.32],0.567860228209725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.74 [0.26-2.08],0.568972999515546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.93 [0.71-1.2],0.569775969187262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.86-1.09],0.572410338112341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,0.95 [0.78-1.15],0.576867730759266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.67 [0.16-2.79],0.580579027311272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.95 [0.77-1.15],0.581565280534659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPC1,Glypican-1,Inverse variance weighted,17,1.04 [0.9-1.2],0.584802175786796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.9 [0.63-1.3],0.585546275635405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.89 [0.58-1.36],0.588376441261087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.06 [0.86-1.29],0.591240145811606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.96 [0.81-1.13],0.592764760870458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSO,Cathepsin O,Inverse variance weighted,6,1.07 [0.83-1.37],0.598197010007078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.03 [0.91-1.17],0.59916946859463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.97 [0.87-1.08],0.599198686296492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.02 [0.94-1.12],0.600624967978093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.95 [0.76-1.17],0.601587654181352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.09 [0.79-1.49],0.60413161615257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.81 [0.36-1.83],0.609446849793649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.02 [0.95-1.09],0.612209143751335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.04 [0.9-1.21],0.61436824548662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.96 [0.82-1.12],0.614636342820995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRP,Agouti-related protein,Inverse variance weighted,3,0.87 [0.49-1.52],0.616895091378199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO1,R-spondin-1,Inverse variance weighted,5,1.07 [0.82-1.39],0.621738445837134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.83 [0.39-1.75],0.621913782389353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.96 [0.84-1.11],0.62282214229106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.19 [0.59-2.4],0.623411900583745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL17C,Interleukin-17C,Inverse variance weighted,3,1.16 [0.64-2.1],0.624372026168511,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.89 [0.56-1.41],0.626555216956051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON2,Spondin-2,Inverse variance weighted,4,1.08 [0.79-1.47],0.62808971307759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS3,Galectin-3,Inverse variance weighted,25,1.03 [0.91-1.18],0.632499506944116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI3,Elafin,Inverse variance weighted,10,1.04 [0.88-1.22],0.638082764872074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.22 [0.53-2.83],0.638304369984849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1.02 [0.94-1.11],0.643010714022427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.96 [0.79-1.16],0.645369650677943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VWC2,Brorin,Inverse variance weighted,22,1.04 [0.89-1.21],0.648112025280719,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.96 [0.8-1.15],0.651062395998781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN4,Nectin-4,Inverse variance weighted,7,1.05 [0.85-1.3],0.652743825939039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.9 [0.55-1.45],0.652897161530082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.53 [0.24-9.81],0.653783067391358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.94-1.11],0.659745311277564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP7,Matrilysin,Inverse variance weighted,13,0.97 [0.84-1.12],0.662502668970177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK8,Kallikrein-8,Inverse variance weighted,12,0.96 [0.78-1.17],0.665951586624572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.87-1.09],0.66661047224727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.93 [0.67-1.29],0.672144942431544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.88-1.22],0.674249538968867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.05 [0.83-1.32],0.674433817504783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.97 [0.85-1.11],0.674969370762369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.17 [0.56-2.42],0.675500015153598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.89 [0.53-1.51],0.67630315966609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.22 [0.48-3.1],0.680736086771466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA2,Apolipoprotein A-II,Wald ratio,1,0.84 [0.37-1.93],0.684575140409059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMB,RGM domain family member B,Inverse variance weighted,9,1.06 [0.79-1.43],0.686476333284963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,0.98 [0.87-1.1],0.687194303530346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.15 [0.59-2.24],0.689400420277509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.98 [0.88-1.09],0.691798536297273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,14,0.97 [0.83-1.13],0.694439691811685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPT,Dermatopontin,Inverse variance weighted,21,1.03 [0.89-1.19],0.694509261821619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGB,Secretogranin-1,Inverse variance weighted,27,1.02 [0.93-1.12],0.698254112724932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH17,Cadherin-17,Inverse variance weighted,14,0.96 [0.77-1.19],0.701093358843715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.07 [0.76-1.51],0.701945509721592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.94 [0.66-1.32],0.702125574790081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [0.88-1.2],0.703858627466965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.96 [0.8-1.16],0.705768206886109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK10,Kallikrein-10,Inverse variance weighted,15,0.97 [0.83-1.14],0.707804277785407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.9 [0.53-1.54],0.709393001568573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK6,Kallikrein-6,Inverse variance weighted,4,1.05 [0.8-1.38],0.711279766201911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.02 [0.91-1.15],0.713375050082743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.1 [0.65-1.88],0.713731121715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.13 [0.59-2.16],0.716448882326761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REN,Renin,Inverse variance weighted,4,1.04 [0.84-1.29],0.71880564066509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCA,Calcitonin,Inverse variance weighted,5,0.92 [0.6-1.42],0.719295837978612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANG,Angiogenin,Inverse variance weighted,19,0.97 [0.84-1.12],0.72097960498993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.04 [0.85-1.27],0.722725320047804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,0.97 [0.82-1.15],0.725578060547064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THBD,Thrombomodulin,Inverse variance weighted,5,0.95 [0.73-1.25],0.732245257603137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH6,Cadherin-6,Inverse variance weighted,29,0.98 [0.9-1.08],0.732578739736666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.06 [0.76-1.48],0.735097899390694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,0.9 [0.49-1.65],0.738571038144909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,1.02 [0.92-1.13],0.741882178768388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.02 [0.91-1.15],0.7427235581611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.02 [0.92-1.12],0.746364677390725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.97 [0.82-1.15],0.748157596766851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AREG,Amphiregulin,Inverse variance weighted,3,0.94 [0.66-1.35],0.748247694723108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.06 [0.72-1.58],0.75615494764475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.73 [0.1-5.19],0.757273750279832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.02 [0.89-1.18],0.75730126378807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.93-1.11],0.762764386649341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.97 [0.78-1.21],0.764282439462566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.02 [0.91-1.14],0.766732266209873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.04 [0.81-1.32],0.768675099847892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBP2,Retinol-binding protein 2,Wald ratio,1,0.87 [0.35-2.16],0.76886773055224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.89-1.09],0.769601772318007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.98 [0.85-1.13],0.774622510178151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS1,Galectin-1,Inverse variance weighted,6,0.98 [0.83-1.15],0.779182942792557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.02 [0.9-1.15],0.77993148992875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PKD1,Polycystin-1,Inverse variance weighted,12,1.03 [0.85-1.24],0.781613347920204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.96 [0.73-1.27],0.782757838515093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH1,Cadherin-1,Wald ratio,1,0.85 [0.26-2.76],0.783275330317132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.03 [0.83-1.28],0.786403818130754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ELN,Elastin,Inverse variance weighted,2,0.82 [0.2-3.39],0.787371725350048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.12 [0.48-2.63],0.790928439802095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.06 [0.7-1.59],0.792091630052518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,1.01 [0.94-1.09],0.792375555418743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG2,Desmoglein-2,Inverse variance weighted,11,1.02 [0.85-1.23],0.794711227257436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP10,Stromelysin-2,Inverse variance weighted,22,1.02 [0.89-1.16],0.79496800809798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.85 [0.25-2.9],0.798022152551234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.04 [0.78-1.37],0.798280743355003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.01 [0.92-1.12],0.798991986195641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.09 [0.57-2.08],0.799883426778912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.03 [0.83-1.27],0.800236186625304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.03 [0.81-1.32],0.801870816674504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN2,Nectin-2,Inverse variance weighted,5,1.02 [0.87-1.19],0.802744033742242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPARCL1,SPARC-like protein 1,Inverse variance weighted,35,1.01 [0.93-1.09],0.811590029081036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.01 [0.9-1.14],0.819220322939867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.16 [0.32-4.26],0.819492702474625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.03 [0.82-1.29],0.819742172122715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGA,Chromogranin-A,Inverse variance weighted,3,0.97 [0.73-1.28],0.822268093323824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1.01 [0.94-1.08],0.823766363606744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSB,Cathepsin B,Inverse variance weighted,26,1.01 [0.91-1.13],0.824217220051931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG3,Desmoglein-3,Inverse variance weighted,7,1.02 [0.84-1.25],0.827884846255974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL19,Interleukin-19,Inverse variance weighted,11,1.02 [0.87-1.2],0.829275436105016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.82-1.17],0.829602574451253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN3,CCN family member 3,Inverse variance weighted,19,1.02 [0.84-1.24],0.834446894185185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,0.99 [0.9-1.09],0.839646265576549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.02 [0.82-1.27],0.846989259428555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.03 [0.78-1.35],0.849501664979246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PSAP,Prosaposin,Inverse variance weighted,5,0.98 [0.76-1.25],0.851538100151298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPP1,Osteopontin,Inverse variance weighted,8,1.05 [0.6-1.85],0.854317362896202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,1.01 [0.9-1.13],0.856830398809145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EGFLAM,Pikachurin,Inverse variance weighted,19,0.99 [0.91-1.09],0.857721315577597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.96 [0.64-1.46],0.859119776597086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,0.99 [0.88-1.12],0.860884019481363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.99 [0.9-1.1],0.864360344245038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRELP,Prolargin,Inverse variance weighted,9,0.99 [0.84-1.16],0.864899836261237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.02 [0.77-1.36],0.866343651942293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.98 [0.81-1.2],0.868540709464907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.01 [0.9-1.13],0.871651141051215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ALCAM,CD166 antigen,Inverse variance weighted,6,0.97 [0.63-1.48],0.872965096298316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.98 [0.72-1.31],0.873436615489291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.98 [0.8-1.21],0.874427104673817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.04 [0.66-1.64],0.877214511861395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.92 [0.34-2.55],0.877549817696633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.02 [0.83-1.25],0.880151122627258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.99 [0.87-1.13],0.880924852360647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD46,Membrane cofactor protein,Wald ratio,1,1.05 [0.56-1.95],0.881036767853077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS2,Trypsin-2,Inverse variance weighted,3,0.97 [0.69-1.38],0.881832866200638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.12 [0.26-4.89],0.881837665112088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,0.99 [0.83-1.18],0.883267612318312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.98 [0.71-1.34],0.894061820478473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.02 [0.8-1.29],0.900744273074846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.01 [0.91-1.11],0.900892473739435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.98 [0.69-1.4],0.905257922456782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MELTF,Melanotransferrin,Inverse variance weighted,40,1 [0.92-1.08],0.906028452024327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.02 [0.68-1.55],0.906935361064459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.88-1.15],0.908185046824976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.08 [0.3-3.84],0.908968890230403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.01 [0.82-1.26],0.909937993589114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.01 [0.82-1.25],0.916843442802378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1 [0.93-1.07],0.921351856002881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.01 [0.81-1.26],0.925691972606527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEPTIN8,Septin-8,Inverse variance weighted,2,0.98 [0.66-1.45],0.925982419800105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1 [0.91-1.09],0.928175950412993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,0.99 [0.84-1.17],0.934340252030083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,29,1.01 [0.89-1.14],0.936423251642429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.99 [0.82-1.2],0.937665829274874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.98 [0.65-1.49],0.942614378060881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.01 [0.83-1.23],0.942651028578835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.9-1.11],0.944464383892789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OGN,Mimecan,Inverse variance weighted,30,0.99 [0.84-1.17],0.948008978166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.02 [0.63-1.63],0.950273747122844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.99 [0.84-1.18],0.952149937218718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.92-1.08],0.961978964437541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.02 [0.36-2.91],0.964594742274724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALB2,Calretinin,Wald ratio,1,1.02 [0.42-2.49],0.965350018285984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CX3CL1,Fractalkine,Inverse variance weighted,9,1.01 [0.73-1.39],0.967223396025577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.03 [0.21-4.99],0.968142024812284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.01 [0.61-1.66],0.968420342980759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS8,Prostasin,Inverse variance weighted,5,1.01 [0.58-1.76],0.97376471750299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VASN,Vasorin,Inverse variance weighted,14,1 [0.9-1.11],0.974255670897312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTBDN,Retbindin,Inverse variance weighted,3,1 [0.74-1.35],0.984596909510131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.84-1.2],0.984660605642213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,1 [0.88-1.13],0.985791438906743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGB6,Integrin beta-6,Inverse variance weighted,11,1 [0.85-1.17],0.990201302828864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KITLG,Kit ligand,Wald ratio,1,1.01 [0.34-2.98],0.990404882330488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,1 [0.67-1.48],0.993588504398003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO3,R-spondin-3,Inverse variance weighted,6,1 [0.75-1.33],0.997508671296169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,3.89 [2.12-7.13],1.15552496958273e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS3,Galectin-3,Inverse variance weighted,15,1.67 [1.3-2.15],7.07297878829267e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK6,Kallikrein-6,Inverse variance weighted,2,3.56 [1.7-7.49],0.000799686032259383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,6.29 [1.94-20.39],0.00217472211956715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM2,Paralemmin-2,Inverse variance weighted,9,1.4 [1.13-1.75],0.00227175555931537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSC2,Desmocollin-2,Inverse variance weighted,16,0.78 [0.66-0.92],0.00265476130597731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,2.32 [1.34-4.02],0.0027507067661895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3C,Protein FAM3C,Inverse variance weighted,3,2.4 [1.32-4.37],0.00412237547632326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.59 [0.41-0.85],0.00453106479010437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.62 [0.45-0.87],0.0055568640022521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.76 [1.18-2.64],0.00589009242537063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON1,Spondin-1,Inverse variance weighted,4,2.18 [1.23-3.85],0.00724209607565937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.32 [1.07-1.61],0.00808826447848395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCA,Calcitonin,Inverse variance weighted,13,0.64 [0.46-0.9],0.00974484326181394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.51 [0.3-0.88],0.0155601051659133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTBDN,Retbindin,Inverse variance weighted,2,2.42 [1.17-5.01],0.0177164456573361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.75 [0.6-0.95],0.0180125109137593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.43 [0.21-0.87],0.0180640953480012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WNT9A,Protein Wnt-9a,Wald ratio,1,6.23 [1.34-29.03],0.0197361714982649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.43 [0.21-0.91],0.0272103270451093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLK1,Protein delta homolog 1,Inverse variance weighted,10,1.51 [1.05-2.18],0.0273138043733783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.2 [1.02-1.41],0.0281920924289448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.66 [1.05-2.61],0.0304183469746669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.49 [1.04-2.13],0.0305451359745942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,17,1.25 [1.01-1.55],0.037259442265821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.89 [0.79-1],0.0411637276666394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.25 [1.01-1.55],0.0416295331689833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.1 [1-1.21],0.0422893558467376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,2.15 [1.02-4.54],0.0443141172317536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.65 [1.01-2.68],0.0446119443485286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLL1,Delta-like protein 1,Inverse variance weighted,6,2.02 [1.01-4.02],0.0455902703988466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.17 [1-1.38],0.0456643597863307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THBD,Thrombomodulin,Inverse variance weighted,11,1.22 [1-1.5],0.0503012818686739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.26 [1-1.6],0.0520711640614291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,0.83 [0.69-1],0.0537021289758922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.8 [0.98-3.31],0.0562487084190142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MATN2,Matrilin-2,Inverse variance weighted,28,0.91 [0.82-1],0.0576648183714192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.58 [0.33-1.02],0.0577508623612095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.14 [1-1.32],0.0581972392452594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.37 [0.99-1.91],0.0604751377615224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.54 [0.98-2.41],0.0613167667749887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.81 [0.64-1.01],0.0614600226060644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP10,Stromelysin-2,Wald ratio,1,0.27 [0.07-1.07],0.0618463710166743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,0.88 [0.77-1.01],0.0643156120369586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.89 [0.79-1.01],0.0651723182177247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH3,Cadherin-3,Inverse variance weighted,10,0.74 [0.54-1.02],0.0679445248045232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,2.3 [0.94-5.62],0.0686585524575581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,2.01 [0.95-4.25],0.0693863576110587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.38 [0.97-1.95],0.0707692804543872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPT,Dermatopontin,Inverse variance weighted,4,0.43 [0.17-1.08],0.070995652510898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGB,Secretogranin-1,Inverse variance weighted,7,1.47 [0.97-2.23],0.0728502066469806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.53 [0.27-1.06],0.0736418833688538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.4 [0.97-2.03],0.0749578973619111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.88 [0.77-1.01],0.0766289433116899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSO,Cathepsin O,Inverse variance weighted,19,1.21 [0.98-1.48],0.0779004722143175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.92 [0.84-1.01],0.0803122601274663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.85 [0.71-1.02],0.0808140351430883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,2.15 [0.91-5.07],0.0815975273957684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN5,CCN family member 5,Inverse variance weighted,12,0.85 [0.7-1.02],0.0847572609660187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.63 [0.93-2.88],0.0884917078644579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD302,CD302 antigen,Inverse variance weighted,11,0.8 [0.61-1.04],0.0926069865559508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.22 [0.97-1.53],0.0931013659265159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.42 [0.94-2.13],0.0939847208455178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,3.95 [0.79-19.85],0.0953105626160567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,0.94 [0.88-1.01],0.0965993948802059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.09 [0.98-1.21],0.0972376425273665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.36 [0.1-1.22],0.0993438254297906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.35 [0.1-1.25],0.10678020991322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.29 [0.95-1.77],0.107316783769182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.79 [0.88-3.64],0.109482490866155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.28 [0.94-1.73],0.11302857758184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH7,Protocadherin-7,Inverse variance weighted,3,1.72 [0.88-3.38],0.113288447435301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.47 [0.18-1.2],0.113365309453165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,XG,Glycoprotein Xg,Inverse variance weighted,2,0.44 [0.16-1.22],0.115269244242969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.05 [0.99-1.11],0.117161944609502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.51 [0.9-2.55],0.118691860801433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAYN,Layilin,Inverse variance weighted,3,1.9 [0.85-4.29],0.119796190229737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,1.08 [0.98-1.19],0.12188242089952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.44 [0.91-2.27],0.123139728027644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NXPH3,Neurexophilin-3,Inverse variance weighted,19,0.91 [0.8-1.03],0.124675938046483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.7 [0.86-3.36],0.125105869371363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.72 [0.86-3.43],0.12625690661615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.67 [0.4-1.12],0.127405514268072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.75 [0.51-1.1],0.139910975417417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.92 [0.82-1.03],0.140964673534907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,1.72 [0.83-3.53],0.142170811252239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPP1,Osteopontin,Inverse variance weighted,13,1.33 [0.91-1.96],0.142285137884054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST3,Cystatin-C,Inverse variance weighted,3,1.74 [0.83-3.66],0.14425272097945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.16 [0.95-1.42],0.147424260004824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.09 [0.97-1.23],0.147444380369373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.47 [0.87-2.49],0.152412565827653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.44 [0.87-2.38],0.152878949515977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.79 [0.58-1.09],0.154254724756593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.17 [0.94-1.45],0.158426819103691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.77 [0.54-1.11],0.158865017614571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LMNB2,Lamin-B2,Inverse variance weighted,8,0.73 [0.48-1.13],0.159284475025594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGA,Chromogranin-A,Inverse variance weighted,5,0.72 [0.46-1.14],0.163315484080095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,1.19 [0.93-1.51],0.163499335105868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.26 [0.91-1.74],0.164122345141383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL16,Pro-interleukin-16,Inverse variance weighted,6,1.49 [0.84-2.64],0.167566745135291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.31 [0.89-1.93],0.16956214622378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.82 [0.63-1.09],0.169565662724906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,0.96 [0.89-1.02],0.176523243983826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.83 [0.64-1.09],0.176598061606269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.08 [0.96-1.21],0.179421284448657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK6,Serine protease inhibitor Kazal-type 6,Wald ratio,1,0.41 [0.11-1.5],0.180455930977614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.91 [0.74-4.93],0.180600699608762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.81 [0.76-4.34],0.182019228626473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.19 [0.92-1.55],0.183595662715854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.87 [0.72-1.07],0.18450314082715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.77 [0.52-1.14],0.191090172749529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.22 [0.9-1.65],0.193909099275498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.3 [0.87-1.92],0.197220294407642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,0.76 [0.5-1.15],0.197479340550457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRN,Agrin,Inverse variance weighted,14,1.28 [0.87-1.88],0.202472358798367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.41 [0.1-1.64],0.208155492672288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.66 [0.75-3.68],0.208746183544554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.54 [0.78-3.03],0.210604362001506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.7 [0.4-1.23],0.211541700694861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO3,R-spondin-3,Inverse variance weighted,5,1.42 [0.81-2.5],0.216373563343644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.66 [0.74-3.74],0.218533187953492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.63 [0.31-1.31],0.219094684639649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS27,Serine protease 27,Inverse variance weighted,47,0.94 [0.85-1.04],0.219868751225694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.83 [0.61-1.12],0.22138209958886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.17 [0.91-1.5],0.221933851915424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.76 [0.49-1.18],0.226222078259383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH17,Cadherin-17,Inverse variance weighted,31,1.08 [0.95-1.21],0.230111271252636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.42 [0.8-2.5],0.231672516286263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NFASC,Neurofascin,Inverse variance weighted,6,0.63 [0.3-1.34],0.232589566673539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.71 [0.41-1.25],0.23290829839325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.58 [0.23-1.43],0.233243887056834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.44 [0.11-1.7],0.23375868597401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.05 [0.97-1.13],0.233917699060432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.86 [0.67-1.1],0.234497472254769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON2,Spondin-2,Inverse variance weighted,3,0.61 [0.27-1.39],0.238452205076039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.2 [0.88-1.63],0.242042878614774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.88 [0.71-1.09],0.244894803583418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP6,Gastrotropin,Inverse variance weighted,4,0.55 [0.2-1.52],0.249930819783849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.22 [0.87-1.72],0.254593744317609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.8 [0.54-1.18],0.254637587202519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK4,Kallikrein-4,Inverse variance weighted,5,0.67 [0.34-1.34],0.257375418923725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.39 [0.08-1.99],0.260151092651239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.19 [0.88-1.6],0.262460843040437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN4,CCN family member 4,Inverse variance weighted,29,1.08 [0.94-1.23],0.263832407642052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.15 [0.9-1.48],0.264969258168996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGF,Placenta growth factor,Inverse variance weighted,5,0.65 [0.3-1.39],0.266826151961682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.19 [0.88-1.6],0.268514150069628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.92 [0.8-1.06],0.269066557673455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.1 [0.93-1.3],0.269820082222085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.11 [0.92-1.33],0.271974836036265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.8 [0.53-1.2],0.27836605983114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.3 [0.81-2.08],0.27901767647519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.86 [0.65-1.13],0.281774850189993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,0.86 [0.66-1.13],0.284754205710411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,1.76 [0.62-4.99],0.2848306221786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.54 [0.17-1.67],0.284849092500212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.69 [0.35-1.36],0.285603026457423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HEPH,Hephaestin,Inverse variance weighted,6,1.14 [0.9-1.45],0.286550141078243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,1.2 [0.86-1.68],0.291527946160808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.08 [0.93-1.26],0.293077330979921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AREG,Amphiregulin,Inverse variance weighted,5,1.31 [0.79-2.15],0.293302327782437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FBLN2,Fibulin-2,Inverse variance weighted,6,0.76 [0.45-1.28],0.295088056700416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VWC2,Brorin,Inverse variance weighted,12,1.35 [0.77-2.39],0.295713012770329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.83 [0.59-1.17],0.297304733752369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KITLG,Kit ligand,Inverse variance weighted,30,1.1 [0.92-1.32],0.297649984234325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1.21 [0.85-1.72],0.29952371922279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.91 [0.77-1.08],0.302801032689347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.05 [0.95-1.16],0.303432267247098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM,Paralemmin-1,Inverse variance weighted,4,0.76 [0.45-1.28],0.303972607567849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.58 [0.21-1.63],0.305130615202723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSTB,Cystatin-B,Inverse variance weighted,23,1.06 [0.95-1.18],0.312009819624957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.41 [0.72-2.76],0.312516911697957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,15,0.85 [0.62-1.17],0.328990512531043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRELP,Prolargin,Inverse variance weighted,5,0.7 [0.34-1.43],0.329429938345257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP7,Matrilysin,Wald ratio,1,0.78 [0.47-1.29],0.32979454231531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.09 [0.92-1.28],0.330066078611105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.18 [0.85-1.64],0.330803941192112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.66 [0.28-1.53],0.331359564389707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.73 [0.38-1.39],0.334472068567234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.21 [0.82-1.8],0.335819103866584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,9,1.32 [0.75-2.35],0.336822706407176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK11,Kallikrein-11,Inverse variance weighted,13,1.14 [0.87-1.51],0.339073290251656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.15 [0.86-1.56],0.344329607533276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.94 [0.82-1.07],0.345068124875058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.85 [0.61-1.19],0.346972186667353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.2 [0.82-1.77],0.349960154816949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.09 [0.91-1.32],0.351302366527455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.37 [0.7-2.71],0.358954373416738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.51 [0.63-3.64],0.359199484773863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MELTF,Melanotransferrin,Inverse variance weighted,10,1.2 [0.81-1.78],0.363723268383791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.39 [0.68-2.84],0.366303051826668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.17 [0.83-1.65],0.36895688988497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.68 [0.3-1.57],0.369801035884096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1.08 [0.91-1.28],0.370105331694192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.19 [0.81-1.73],0.373627473394508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.93 [0.79-1.09],0.378346256995752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.87 [0.63-1.19],0.380129588929016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.27 [0.74-2.17],0.383814123958025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.09 [0.9-1.32],0.385692260222625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.78 [0.45-1.36],0.38580773989675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.83 [0.54-1.28],0.393350655390593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO1,R-spondin-1,Inverse variance weighted,8,0.84 [0.55-1.27],0.400408957159902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.13 [0.85-1.49],0.40322496472683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.91 [0.72-1.14],0.411011975520601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.95 [0.84-1.07],0.41492154789226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.13 [0.84-1.52],0.415076832593482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,XCL1,Lymphotactin,Inverse variance weighted,15,0.86 [0.6-1.24],0.415266896369139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.41 [0.62-3.2],0.415479190265604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EGFLAM,Pikachurin,Wald ratio,1,0.49 [0.09-2.78],0.41844378399956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS8,Prostasin,Inverse variance weighted,14,1.12 [0.85-1.46],0.421269701219445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.73 [0.45-6.62],0.422263152058298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.87 [0.61-1.23],0.424224626102943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.85 [0.56-1.28],0.427363662742896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.96 [0.87-1.06],0.431077312937903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.18 [0.78-1.77],0.431675330276182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.62 [0.18-2.08],0.435172084683282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.18 [0.77-1.82],0.438738305222132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,22,0.9 [0.68-1.19],0.44244049399823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.11 [0.85-1.44],0.443611509996708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.07 [0.9-1.26],0.444330928303281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GUCA2A,Guanylin,Inverse variance weighted,7,0.81 [0.48-1.38],0.445470449144606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,F3,Tissue factor,Inverse variance weighted,13,1.14 [0.81-1.59],0.446954709495575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.81-1.63],0.448206046896462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.13 [0.82-1.55],0.448622807909441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.21 [0.74-1.96],0.450894080610394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.79 [0.42-1.46],0.451519820293094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.85 [0.55-1.3],0.455990470507164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RETN,Resistin,Inverse variance weighted,19,0.89 [0.65-1.21],0.45615784215832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.77 [0.39-1.52],0.456364099867176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,0.84 [0.54-1.32],0.461031136667074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.68 [0.42-6.7],0.462530496914713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,0.96 [0.86-1.07],0.465390857315188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.14 [0.8-1.64],0.465835938372273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.35 [0.6-3],0.467941557350021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.88 [0.62-1.25],0.471766466149559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.74 [0.31-1.72],0.477735551160807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.26 [0.67-2.38],0.478018853775911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,1.23 [0.69-2.17],0.479440173020158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN2,Nectin-2,Inverse variance weighted,3,0.72 [0.3-1.77],0.480628719807755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.85 [0.54-1.33],0.482806222880749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ALCAM,CD166 antigen,Inverse variance weighted,4,0.88 [0.61-1.26],0.483569438557976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.7 [0.26-1.91],0.48854779526142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,0.93 [0.76-1.14],0.489171788697166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.93 [0.76-1.14],0.490420579920059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.92 [0.72-1.17],0.491672218946849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.11 [0.83-1.47],0.491704779073658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.73 [0.3-1.78],0.492486953215976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.82 [0.47-1.44],0.495988699493051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.97 [0.87-1.07],0.496099506978739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,1.11 [0.83-1.48],0.496485996841915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.12 [0.8-1.57],0.500049988832196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPC1,Glypican-1,Inverse variance weighted,28,0.94 [0.8-1.12],0.50704542706592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.73 [0.29-1.85],0.50935233934593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.81 [0.43-1.52],0.51036432888617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,1.3 [0.6-2.81],0.511606296945865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCG2,Secretogranin-2,Inverse variance weighted,2,1.43 [0.49-4.14],0.512580228294684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.58 [0.4-6.2],0.513701217367128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.96 [0.86-1.08],0.514723024908678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK10,Kallikrein-10,Wald ratio,1,0.62 [0.15-2.63],0.51748985774157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.78 [0.37-1.65],0.517663506296358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.88 [0.6-1.29],0.518558109169877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.92 [0.72-1.19],0.527727779804143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PENK,Proenkephalin-A,Inverse variance weighted,15,1.09 [0.82-1.45],0.53459726789294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.24 [0.62-2.46],0.540941333438024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.07 [0.86-1.34],0.54371282973673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REN,Renin,Inverse variance weighted,8,0.88 [0.6-1.32],0.54469061404687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.81 [0.4-1.63],0.547323867878431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,6,1.2 [0.66-2.2],0.548029176325771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.09 [0.83-1.43],0.549103105496045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.2 [0.66-2.17],0.549989212572705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.09 [0.82-1.43],0.553697074843793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.19 [0.67-2.13],0.554782167686279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP3,Stromelysin-1,Inverse variance weighted,4,0.8 [0.39-1.66],0.557559589130423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BOC,Brother of CDO,Inverse variance weighted,8,0.9 [0.62-1.29],0.559937437241297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.96 [0.83-1.11],0.561334601495066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,1.32 [0.52-3.37],0.563173228103805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.27 [0.56-2.85],0.566351808238381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.13 [0.75-1.7],0.566525555570174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.79-1.14],0.566536197243615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.07 [0.86-1.33],0.567320827851457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.88 [0.56-1.38],0.567915995943119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.22 [0.62-2.4],0.568578542808358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.16 [0.69-1.95],0.575599441325256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.32 [0.5-3.45],0.576964697415227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.93 [0.72-1.2],0.577363843406868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.19 [0.64-2.22],0.57979485384729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.92 [0.7-1.23],0.579959114159434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.29 [0.52-3.2],0.580421960199017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST6,Cystatin-M,Inverse variance weighted,26,0.94 [0.75-1.18],0.585055492359322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.89 [0.57-1.37],0.586170513414168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.91 [0.64-1.29],0.593201586974941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.89 [0.59-1.36],0.597090471111035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,19,1.04 [0.91-1.19],0.597950699864709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.06 [0.85-1.31],0.602523772774006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEPTIN8,Septin-8,Inverse variance weighted,4,0.84 [0.44-1.62],0.605265514950252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.02 [0.95-1.09],0.605357759204099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.17 [0.63-2.17],0.611097559205812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL11,Eotaxin,Inverse variance weighted,11,1.05 [0.87-1.27],0.61202377126047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI3,Elafin,Inverse variance weighted,18,1.05 [0.87-1.25],0.616136653859451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSL,Cathepsin L1,Inverse variance weighted,29,0.96 [0.8-1.14],0.617402974949695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.19 [0.6-2.36],0.619761113150748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.22 [0.56-2.64],0.620406797346442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1.08 [0.8-1.45],0.62338942740253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.9 [0.59-1.37],0.623953259381464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.12 [0.71-1.78],0.624254770914297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.88 [0.53-1.46],0.625621991984153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.96 [0.82-1.13],0.625762138525138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.75 [0.24-2.36],0.626765686919796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.06 [0.83-1.35],0.632957525984977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.19 [0.58-2.42],0.634048054116579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,0.88 [0.51-1.51],0.635667248841341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.9 [0.58-1.39],0.636685810888854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.03 [0.91-1.17],0.639400427391239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL19,Interleukin-19,Inverse variance weighted,10,1.04 [0.88-1.23],0.641358237071599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.9 [0.58-1.4],0.64221505195882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COLEC12,Collectin-12,Inverse variance weighted,3,0.84 [0.39-1.8],0.645898812347055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.93 [0.7-1.25],0.6469216194148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DCN,Decorin,Inverse variance weighted,2,1.25 [0.48-3.25],0.648758807454782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.87-1.09],0.650955455245627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.94 [0.73-1.22],0.651717371522214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.06 [0.82-1.38],0.657391979163442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.85 [0.42-1.73],0.661533929518432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.21 [0.5-2.91],0.667229092964568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.82 [0.33-2.02],0.669176042423335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.94-1.11],0.669207073386076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,1.08 [0.74-1.58],0.672474498547874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.09 [0.73-1.62],0.674534088245845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CAPG,Macrophage-capping protein,Wald ratio,1,1.24 [0.44-3.48],0.676644166957709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALB1,Calbindin,Inverse variance weighted,9,0.91 [0.58-1.43],0.681613430247033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GCG,Pro-glucagon,Inverse variance weighted,2,1.67 [0.15-19.06],0.681699887175609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.95 [0.75-1.21],0.683278206501186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.88 [0.47-1.65],0.683786521274735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.08 [0.74-1.58],0.686851389511637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN15,Lipocalin-15,Inverse variance weighted,22,1.02 [0.91-1.15],0.687723928326334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.21 [0.47-3.09],0.688844788595958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.86 [0.41-1.79],0.688926698911206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.95 [0.75-1.21],0.689907588111774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.97 [0.84-1.13],0.697623513638036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN4,Nectin-4,Inverse variance weighted,4,0.89 [0.47-1.66],0.704849480863108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.04 [0.84-1.3],0.705471347226428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.15 [0.56-2.36],0.707670492730605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,1.06 [0.79-1.41],0.710025142806201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.9 [0.53-1.54],0.710330990549926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.11 [0.64-1.92],0.711330429912083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.07 [0.75-1.51],0.711687482502237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MB,Myoglobin,Inverse variance weighted,9,0.91 [0.55-1.5],0.712331028886983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NRP1,Neuropilin-1,Inverse variance weighted,14,1.06 [0.79-1.41],0.713110305261599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMB,RGM domain family member B,Inverse variance weighted,5,0.82 [0.29-2.33],0.714207305936643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.82 [0.28-2.39],0.714696058700377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.89 [0.48-1.65],0.715592070044643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRP,Agouti-related protein,Inverse variance weighted,16,0.96 [0.76-1.21],0.718484304317553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MUC13,Mucin-13,Inverse variance weighted,3,1.15 [0.54-2.43],0.718903944499975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.02 [0.93-1.11],0.719085251731078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN3,CCN family member 3,Inverse variance weighted,17,1.04 [0.83-1.32],0.719691880173295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.14 [0.56-2.29],0.721617220806299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.07 [0.75-1.52],0.722015707362444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.97 [0.8-1.17],0.727836389236625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANG,Angiogenin,Inverse variance weighted,9,0.92 [0.57-1.48],0.730436525176749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ELN,Elastin,Inverse variance weighted,10,0.94 [0.65-1.35],0.731298055414846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.94 [0.66-1.34],0.732843172689627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.97 [0.8-1.17],0.733196175565993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SDC1,Syndecan-1,Inverse variance weighted,12,0.95 [0.7-1.28],0.73519620717068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.89-1.08],0.73530524392709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.91 [0.53-1.57],0.735558295283112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH6,Cadherin-6,Inverse variance weighted,5,0.91 [0.53-1.57],0.737780974875333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.03 [0.85-1.26],0.739507107969063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,0.94 [0.65-1.36],0.741488199977321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,40,1.02 [0.9-1.16],0.741516559821866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DRAXIN,Draxin,Inverse variance weighted,25,1.03 [0.85-1.25],0.745184476872209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.04 [0.82-1.31],0.746111559784685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD164,Sialomucin core protein 24,Inverse variance weighted,8,0.95 [0.69-1.3],0.74893756457354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.05 [0.76-1.45],0.750835944872498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.04 [0.83-1.29],0.751881264210065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1.06 [0.73-1.54],0.75214074112803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AMBP,Protein AMBP,Inverse variance weighted,5,0.93 [0.6-1.45],0.753786058087863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL17C,Interleukin-17C,Inverse variance weighted,5,1.09 [0.63-1.87],0.756737598795025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.93 [0.59-1.48],0.765740908895249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.04 [0.82-1.32],0.76797395621257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.04 [0.82-1.31],0.770204316909929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.04 [0.77-1.41],0.774132253730757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.92 [0.5-1.68],0.776247037396736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.92-1.11],0.776435917947381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.88 [0.38-2.08],0.776655768092638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.15 [0.44-2.97],0.777648742544139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,1.02 [0.89-1.16],0.780266942262265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.91 [0.46-1.81],0.781809468488231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.04 [0.79-1.36],0.783007835935182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPARCL1,SPARC-like protein 1,Inverse variance weighted,21,0.97 [0.77-1.22],0.783382811417347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BSG,Basigin,Inverse variance weighted,6,0.91 [0.45-1.85],0.793364928002425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.15 [0.4-3.32],0.793649881317646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.98 [0.8-1.18],0.807836247016352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.97 [0.76-1.24],0.812669583352586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.95 [0.62-1.45],0.812693944185269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VASN,Vasorin,Inverse variance weighted,5,1.12 [0.44-2.89],0.81294557059403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.02 [0.89-1.15],0.818257381137524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.03 [0.79-1.34],0.818341877820777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD276,CD276 antigen,Inverse variance weighted,24,0.98 [0.82-1.17],0.819404649754196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.92 [0.43-1.96],0.825149039772698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.8-1.19],0.826096407942322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.98 [0.78-1.22],0.82700657467668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.05 [0.66-1.69],0.830772591672545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MDK,Midkine,Inverse variance weighted,14,0.97 [0.73-1.3],0.838010845760971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.61-1.5],0.840073718565812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.03 [0.78-1.36],0.840891165103191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK8,Kallikrein-8,Inverse variance weighted,5,0.95 [0.55-1.62],0.84145235371996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.03 [0.76-1.4],0.841633013239406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.05 [0.63-1.77],0.842550023673394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,0.97 [0.71-1.32],0.842699650293219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD83,CD83 antigen,Inverse variance weighted,14,1.04 [0.73-1.48],0.843707542581316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.92 [0.39-2.18],0.853150553025698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.02 [0.84-1.23],0.862252386121164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.05 [0.6-1.82],0.86471232610202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.11 [0.32-3.88],0.872500712577801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD48,CD48 antigen,Inverse variance weighted,14,0.98 [0.72-1.33],0.873634655662716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OCLN,Occludin,Inverse variance weighted,2,1.08 [0.42-2.8],0.874840132787337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.93 [0.35-2.47],0.878659019971544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.07 [0.43-2.66],0.878663932308861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD160,CD160 antigen,Inverse variance weighted,24,0.98 [0.74-1.3],0.879673003747801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.9 [0.21-3.85],0.882695738723191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.92 [0.28-2.98],0.884562878586006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.01 [0.9-1.13],0.888899760338993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.97 [0.65-1.45],0.890057246097081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.96 [0.55-1.69],0.895659339883166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.96 [0.51-1.82],0.896987248442985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.53-2.08],0.898606003972647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.84-1.16],0.899636041607515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS2,Trypsin-2,Inverse variance weighted,17,1.02 [0.8-1.29],0.902871472923517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,0.99 [0.8-1.21],0.903180167885388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.98 [0.76-1.27],0.906420153830978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PKD1,Polycystin-1,Inverse variance weighted,12,0.98 [0.64-1.49],0.9090567751206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CX3CL1,Fractalkine,Inverse variance weighted,12,1.03 [0.65-1.61],0.912067471309028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.99 [0.78-1.24],0.913531994685284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.01 [0.81-1.27],0.914669320818278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.88-1.12],0.915227938741272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.03 [0.6-1.78],0.915487981073152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.02 [0.74-1.4],0.916239483396723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD27,CD27 antigen,Inverse variance weighted,9,1.02 [0.68-1.53],0.925824158048819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS4,Galectin-4,Inverse variance weighted,15,0.99 [0.86-1.14],0.928364556583414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.01 [0.82-1.23],0.930941956987841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.99 [0.75-1.3],0.932672831217054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.99 [0.88-1.13],0.933152165655572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.01 [0.79-1.29],0.93496280006495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.01 [0.82-1.24],0.935658283600569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1 [0.93-1.08],0.935951688338212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.88-1.12],0.938472891033966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,UMOD,Uromodulin,Inverse variance weighted,34,0.99 [0.79-1.24],0.938848868294555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.99 [0.81-1.21],0.940234160183927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.02 [0.54-1.93],0.940402263732468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.01 [0.78-1.3],0.940561439709201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.97 [0.4-2.37],0.94437188368444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.99 [0.63-1.54],0.950189630084362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.99 [0.69-1.41],0.951794471688348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.84-1.21],0.956378316228592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.02 [0.44-2.37],0.956872004548711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OGN,Mimecan,Inverse variance weighted,37,1 [0.89-1.13],0.957275829669335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.99 [0.65-1.51],0.960172751039177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CFD,Complement factor D,Wald ratio,1,0.98 [0.31-3.09],0.965682817165975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.01 [0.6-1.72],0.966795371353095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.66-1.5],0.966837212801315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.99 [0.72-1.38],0.971996612462595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1 [0.7-1.41],0.97861583459277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.89-1.13],0.979713237218414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.01 [0.6-1.68],0.980832826664701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSB,Cathepsin B,Inverse variance weighted,28,1 [0.86-1.17],0.982706714416466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD99,CD99 antigen,Inverse variance weighted,4,1 [0.6-1.67],0.988017705640616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1 [0.69-1.46],0.988879336778793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.01 [0.3-3.36],0.989555275068109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1 [0.63-1.6],0.992394324562944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,1 [0.87-1.15],0.992475054889594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG3,Desmoglein-3,Inverse variance weighted,27,1 [0.87-1.15],0.993760235278938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH1,Cadherin-1,Inverse variance weighted,16,1 [0.78-1.28],0.994679344100791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,14,1 [0.89-1.13],0.997450798387112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1 [0.65-1.54],0.9999659240123,trans
